APA (7th ed.) Citation

SL, T., M, S., DF, M., HM, K., RD, C., WH, S., . . . FS, H. (2014). Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(10), 1020. https://doi.org/10.1200/JCO.2013.53.0105

Chicago Style (17th ed.) Citation

SL, Topalian, et al. "Survival, Durable Tumor Remission, and Long-term Safety in Patients with Advanced Melanoma Receiving Nivolumab." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 32, no. 10 (2014): 1020. https://doi.org/10.1200/JCO.2013.53.0105.

MLA (9th ed.) Citation

SL, Topalian, et al. "Survival, Durable Tumor Remission, and Long-term Safety in Patients with Advanced Melanoma Receiving Nivolumab." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 32, no. 10, 2014, p. 1020, https://doi.org/10.1200/JCO.2013.53.0105.